L-NMMA (citrate)
L-NMMA citrate competitively antagonizes L-arginine, and thus inhibits production of nitric oxide (NO) . L-NMMA is utilized as NO synthase antagonist in experimental settings[1].
Product Specifications
CAS Number
209913-88-2
Product Name Alternative
Methylarginine (citrate) ; Tilarginine (citrate)
UNSPSC
12352211
Target
Endogenous Metabolite; NO Synthase
Type
Reference compound
Related Pathways
Immunology/Inflammation; Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/l-nmma-citrate.html
Smiles
N[C@H](C(O)=O)CCCNC(NC)=N.O=C(O)CC(O)(CC(O)=O)C(O)=O
Molecular Formula
C13H24N4O9
Molecular Weight
380.35
References & Citations
[1]Frey C, et al., L-thiocitrulline. A stereospecific, heme-binding inhibitor of nitric-oxide synthases. J Biol Chem. 1994 Oct 21;269 (42) :26083-91.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 4
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Cytokeratin 17 (E3), CF740 conjugate, 0.1mg/mL
Bcl-2 (100/D5 + 124), CF568 conjugate, 0.1mg/mL
